Corpus overview


MeSH Disease

HGNC Genes

There are no HGNC terms in the subcorpus


There are no transmission terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    The Prevalence SERO of ocular manifestations and ocular samples polymerase chain reaction positivity in patients with COVID 19 - a systematic review and meta-analysis

    Authors: Soumen Sadhu; Sushmitha Arcot Dandapani; Deepmala Mazumdar; Sangeetha Srinivasan; Jyotirmay Biswas

    doi:10.1101/2020.06.29.20142414 Date: 2020-06-30 Source: medRxiv

    Objective: To estimate the prevalence SERO of ocular manifestations and ocular samples polymerase chain reaction (PCR) positivity among COVID 19 patients. Methods: A systematic literature review was performed using search engines (PubMed, Google Scholar, Medrixv and BioRixv) with keywords SARS CoV MESHD 2, novel coronavirus, COVID 19, ocular manifestations, conjunctival congestion, Ocular detection, Polymerase chain reaction, and conjunctivitis MESHD. The measure of heterogeneity was evaluated with the I2 statistic. The pooled proportion of patients presenting with symptoms and ocular samples PCR positivity was estimated. Results: A total of 20 studies (14 studies and 6 case reports) were included in the systematic review and 14 studies were included in the metaanalysis. The pooled prevalence SERO of conjunctivitis MESHD was 5.17% (95% CI: 2.90 to 8.04). Conjunctivitis MESHD was reported as an initial symptom of the disease in 0.858 % (95% CI: 0.31 to 1.67). Common associated features include itching, chemosis, epiphora MESHD epiphora HP. Seven patients (29 %) with conjunctivitis MESHD showed positive results in ocular samples, whereas 13 patients (54%) showed positive only in their nasopharyngeal samples (NPs) or sputum samples and 4 patients (16 %) were negative for both NPs and Sputum as well as ocular samples. The pooled prevalence SERO of ocular PCR positivity was 2.90 % (95% CI: 1.77 to 4.46) vs. NPs 89.8% (95% CI: 78.80 to 79.0). Conclusion: The prevalence SERO of conjunctivitis MESHD and ocular samples PCR positivity among COVID 19 patients was low indicating that the eye is a less affected organ. However, conjunctivitis MESHD may present as the first symptom of the disease making the patient seek medical care at the earliest.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.